IL6 and metabolic syndrome: Upon comparing the biomarker levels of the employees with No Metabolic Syndrome (No MetS) (MetS risk score of 0–2) with that of those with a MetS risk score of 3–5, the level of MDA, the end product of lipid peroxidation, pro-inflammatory markers, IL6 and IL-4 and Hcy, oxidative stress markers were found to be significantly higher among the employees who had metabolic syndrome (Table 3).